Access cutting-edge small cell lung cancer treatment through this clinical trial at a research site in Springfield. Study-provided care at no cost to qualified participants.
Access small cell lung cancer specialists in Springfield at no cost
This study follows strict safety protocols and ethical guidelines
All study-related small cell lung cancer treatment provided free
The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated extensive stage small cell lung cancer (ES-SCLC). The primary objectives of this study are to compare the effect of SG to SOC on objective response rate (ORR) as assessed by blinded independent central review (BICR) according to the Response Evaluation Criteria in Solid Tumors and to compare the effe
Sponsor: Gilead Sciences
Check if you qualify for this small cell lung cancer clinical trial in Springfield, IL
If you're searching for small cell lung cancer treatment options in Springfield, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Springfield research site is actively enrolling participants for this clinical trial. You'll receive care from experienced small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.